FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 88 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $21,000 | +162.5% | 4,610 | +122.3% | 0.01% | +150.0% |
| Q3 2019 | $8,000 | +166.7% | 2,074 | +360.9% | 0.00% | +100.0% |
| Q2 2019 | $3,000 | +200.0% | 450 | +316.7% | 0.00% | – |
| Q4 2018 | $1,000 | -90.0% | 108 | -81.2% | 0.00% | -100.0% |
| Q1 2018 | $10,000 | -33.3% | 574 | +58.1% | 0.01% | -54.5% |
| Q3 2017 | $15,000 | +650.0% | 363 | +536.8% | 0.01% | +266.7% |
| Q1 2017 | $2,000 | -96.2% | 57 | -94.3% | 0.00% | -89.3% |
| Q3 2016 | $52,000 | – | 1,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |